At a glance
ClinicalIndex Comparison RecordN/ACompleted· 337 enrolled
Drug / intervention
clarithromycin (Klacid) granules for oral suspensiondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-center, Post-Marketing Observational Study to Identify the Recovery Time in Children With Lower Respiratory Tract Infections Treated With Klacid Granules for Oral Suspension.
In Brief
An observational study evaluating clarithromycin (Klacid) granules for oral suspension for Lower Respiratory Tract Infection. Completed, enrolled 337 participants across 16 sites.
Detailed Summary
Klacid Granules for Oral Suspension provides short symptoms' recovery time in Thai children with lower respiratory tract infections.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLower Respiratory Tract Infection
CountriesThailand
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2009
Primary CompletionJan 2010
First PostedFeb 2010
TodayJul 2026
First PostedFeb 26, 2010
Enrollment StartApr 1, 2009
Primary CompletionJan 1, 2010
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 16.3 years ago
Interventions
clarithromycin (Klacid) granules for oral suspensiondrug
clarithromycin (Klacid) Granules for Oral Suspension